SONOMA PHARMACEUTICALS, INC. (SNOA) Free cash flow 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.1MFY2026 · since FY2017: -$8.6M → -$4.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$4.1M | -2355.4% |
| FY2025 | -$168,000 | +93.0% |
| FY2024 | -$2.4M | +62.6% |
| FY2023 | -$6.4M | -46.4% |
| FY2022 | -$4.4M | -23.3% |
| FY2021 | -$3.6M | +25.8% |
| FY2020 | -$4.8M | +59.4% |
| FY2019 | -$11.8M | +6.4% |
| FY2018 | -$12.6M | -47.5% |
| FY2017 | -$8.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice